https://www.indianpharmapost.com/shilpa-biologicals-spimaco-sign-mena-licensing-deal-for-pd-1-biosimilars-218602026-09-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/pcg-2026-to-spotlight-indias-billion-dose-challenge-in-complex-therapeutics-218612026-09-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/dop-observes-swachhata-pakhwada-across-nipers-psus-218622026-09-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-reduces-initial-monitoring-time-for-amgens-imdelltra-218632026-09-16T00:00:00+05:30always0.9